Literature DB >> 1745471

Intraamniotic infection in patients with intact membranes and preterm labor.

T L Armer1, P Duff.   

Abstract

The purpose of this review was to determine the frequency of intraamniotic infection in women with preterm labor and intact membranes and to assess the need for amniocentesis in these patients. We reviewed reports in the English language literature from the past 10 years in which the frequency of intraamniotic infection was determined by transabdominal amniocentesis. The 16 studies reviewed demonstrated frequencies of positive cultures that varied from 0 to 61 per cent. This extreme variability seems to be the result of diverse patient populations, dissimilar microbiologic techniques, and different definitions of preterm labor. Advanced cervical dilation and poor response to tocolytic agents were two factors associated with a higher frequency of intraamniotic infection. We conclude that each institution must determine the frequency of intraamniotic infection associated with preterm labor in their patient population. In populations with a high frequency of infection, amniocentesis for microbiologic evaluation is recommended for management of preterm labor, especially in patients who have advanced cervical dilatation or who are unresponsive to tocolytic therapy.

Entities:  

Mesh:

Year:  1991        PMID: 1745471     DOI: 10.1097/00006254-199109000-00002

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  4 in total

1.  The diagnostic performance of the Mass Restricted (MR) score in the identification of microbial invasion of the amniotic cavity or intra-amniotic inflammation is not superior to amniotic fluid interleukin-6.

Authors:  Roberto Romero; Nicholas Kadar; Jezid Miranda; Steven J Korzeniewski; Alyse G Schwartz; Piya Chaemsaithong; Wade Rogers; Eleazar Soto; Francesca Gotsch; Lami Yeo; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2013-12-16

2.  Antibiotic administration can eradicate intra-amniotic infection or intra-amniotic inflammation in a subset of patients with preterm labor and intact membranes.

Authors:  Bo Hyun Yoon; Roberto Romero; Jee Yoon Park; Kyung Joon Oh; JoonHo Lee; Agustin Conde-Agudelo; Joon-Seok Hong
Journal:  Am J Obstet Gynecol       Date:  2019-03-27       Impact factor: 8.661

Review 3.  A risk-benefit assessment of therapies for premature labour.

Authors:  K Higby; C R Suiter
Journal:  Drug Saf       Date:  1999-07       Impact factor: 5.606

4.  In vitro bacterial contamination of amniotic fluid: effects on fluorescence polarization lung maturity testing.

Authors:  R P Heine; S Harding; P Emmett; E Ashwood; R R Lenke
Journal:  Infect Dis Obstet Gynecol       Date:  1995
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.